A CONTROLLED EVALUATION OF TWO BENZODIAZEPINE DERIVATES IN THE MANAGEMENT OF MENTALLY RETARDED, CEREBRAL-PALSIED PATIENTS.
D000293:Adolescent; D000927:Anticonvulsants; D001264:Athetosis; D001569:Benzodiazepines; D035843:Biomedical Research; D002547:Cerebral Palsy; D002648:Child; D002707:Chlordiazepoxide; D003975:Diazepam; D004358:Drug Therapy; D006801:Humans; D008607:Intellectual Disability; D009125:Muscle Relaxants, Central; D009460:Neurologic Examination; D019989:Persons with Intellectual Disabilities; D013035:Spasm; D014149:Tranquilizing Agents
D000927:Anticonvulsants; D009125:Muscle Relaxants, Central; D014149:Tranquilizing Agents; D001569:Benzodiazepines; D002707:Chlordiazepoxide; D003975:Diazepam
ADOLESCENCE; ANTICONVULSANTS; ATHETOSIS; CEREBRAL PALSY; CHILD; CHLORDIAZEPOXIDE; CLINICAL RESEARCH; DIAZEPAM; DRUG THERAPY; MENTAL RETARDATION; MUSCLE RELAXANTS; NEUROLOGIC EXAMINATION; SPASM; TRANQUILIZING AGENTS